Novo Nordisk hands over Parkinson’s therapy to AI startup
· Financial Post
Novo Nordisk A/S agreed to hand over an experimental therapy for Parkinson’s disease to a Mark Zuckerberg-backed AI startup to potentially speed its development. Read More
Visit somethingsdifferent.biz for more information.